zoledronic acid has been researched along with Epstein-Barr Virus Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altvater, B; Bisping, G; Bollard, CM; Hansmeier, A; Juergens, H; Landmeier, S; Moosmann, A; Pscherer, S; Rossig, C; Varnholt, L | 1 |
1 other study(ies) available for zoledronic acid and Epstein-Barr Virus Infections
Article | Year |
---|---|
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.
Topics: Antigen-Presenting Cells; Antigens, Viral; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Diphosphonates; Epitopes; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Imidazoles; Immunotherapy; Receptors, Antigen, T-Cell, gamma-delta; Transduction, Genetic; Tumor Necrosis Factor-alpha; Zoledronic Acid | 2009 |